Katharina C. Kahler
Rosalind Franklind Str. 7
Kiel, SH 24105, Germany
Kiel, SH 24105, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 03, 2025
Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.
Journal: Journal of cancer research and clinical oncology
Published: July 30, 2024
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.
Journal: Journal of cancer research and clinical oncology
Published: February 23, 2024
Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 23, 2021
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 28, 2020
67-year-old male with cervical lymph node swelling : Preparation for the specialist examination: part 45
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
Published: April 13, 2019
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.
Journal: Cancer immunology, immunotherapy : CII
Published: September 04, 2017
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 07, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 11, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 30, 2016
Adjuvant systemic treatment of melanoma
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
Published: June 10, 2011
Last Updated: 09/26/2026